Nurix Therapeutics: Wells Fargo cuts target price to $20 from $25
NRIX•Wells Fargo cut its target price for Nurix Therapeutics to $20 from $25.
Related News
Lifecore Biomedical Q3 revenue misses estimates as CDMO, HA sales decline
LFCR•
Siebert Financial says interest rates pose greater constraint on AI buildout than election results
SIEB•
Flutter pauses share buybacks to focus on deleveraging, cost savings
FLUT•
CS Disco names Mich Razon CTO, Johann Wrede CMO
LAW•
Shoals Technologies Q3 revenue beats on strong demand, higher project volumes
SHLS•